Molecular mechanism of miR-27a-3p targeting FBXW7 regulating the malignant behavior of osteosarcoma cells

Huaibin Zhang1, Rongxuan Liu2,3, Xiaorong Liu4

  • 1Department of Orthopedics, The First Hospital of Lanzhou University, Lanzhou, China.

Abstract

Insights

High miR-27a-3p expression promotes osteosarcoma progression by inhibiting FBXW7. This microRNA/gene axis drives cell proliferation and migration, offering potential therapeutic targets for this bone cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma is a prevalent bone cancer in adolescents with poor prognosis.
  • Recurrence, metastasis, and chemoresistance limit current osteosarcoma treatments.
  • MicroRNAs (miRNAs) regulate cancer cell behavior; miR-27a-3p's role in osteosarcoma is unclear.

Purpose of the Study:

  • Investigate the role of miR-27a-3p in osteosarcoma cell behavior.
  • Elucidate the molecular mechanism of miR-27a-3p in osteosarcoma.
  • Identify potential therapeutic targets for osteosarcoma.

Main Methods:

  • Real-time PCR and Western blot for miRNA and protein expression.
  • Bioinformatics and dual luciferase reporter assay to confirm miR-27a-3p targeting of FBXW7.
  • Cell proliferation, migration, and apoptosis assays following miR-27a-3p and FBXW7 manipulation.

Main Results:

  • miR-27a-3p was highly expressed in osteosarcoma cells.
  • miR-27a-3p overexpression promoted proliferation and migration, while inhibiting apoptosis.
  • miR-27a-3p targets FBXW7, influencing osteosarcoma cell behavior, potentially via the Wnt/β-catenin pathway.

Conclusions:

  • High miR-27a-3p expression promotes osteosarcoma cell proliferation and migration by downregulating FBXW7.
  • The miR-27a-3p/FBXW7 axis is functionally linked to malignant behaviors in osteosarcoma.
  • Targeting the miR-27a-3p/FBXW7 pathway may offer novel therapeutic strategies for osteosarcoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...